2025-11-15 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data, presented in the requested format.

## Procter & Gamble (PG) Analysis

**0) Executive Summary:**

Procter & Gamble (PG) is underperforming the S&P 500 significantly in terms of cumulative return. Recent market indicators suggest it's a medium-risk investment with a potential for long-term outperformance relative to the S&P 500. Analyst consensus leans towards a "Buy".
Here's the breakdown:

**1) Performance Analysis:**

*   **Ticker:** PG
*   **Company:** Procter & Gamble Co
*   **Description:** Procter & Gamble is a multinational consumer goods corporation that provides branded consumer packaged goods to consumers across the world.
*   **PG Cumulative Return:** 29.15%
*   **VOO (S&P 500) Cumulative Return:** 98.45%
*   **Return Disparity:** (Max: 24.9, Min: -73.5, Current: -71.5, Relative Disparity: 2.0)
    *   The significant negative disparity indicates PG has vastly underperformed the S&P 500 over the tracked period. The relative disparity of 2.0 suggests the current underperformance is near the bottom of its historical range relative to the S&P 500.

*   **Alpha/Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha   | Beta    | Cap(B)  |
| :----------- | :------- | :------- | :------ | :------ | :------ |
| 2015-2017  | 21.0%    | 7.9%    | -7.0%   | 0.0     | 215.1   |
| 2016-2018  | 9.0%     | 67.3%   | -6.0%   | 0.0     | 215.2   |
| 2017-2019  | 24.0%    | 70.4%   | 2.0%    | 0.3     | 292.4   |
| 2018-2020  | 27.0%    | 78.8%   | 4.0%    | 0.4     | 325.8   |
| 2019-2021  | 41.0%    | 78.8%   | -5.0%   | 0.5     | 383.0   |
| 2020-2022  | 13.0%    | 79.4%   | 13.0%   | 0.6     | 354.9   |
| 2021-2023  | 26.0%    | 79.4%   | 24.0%   | 0.4     | 343.1   |
| 2022-2024  | 9.0%     | 79.4%   | -12.0%  | 0.4     | 392.5   |
| 2023-2025  | -15.0%   | 80.1%   | -78.0%  | 0.2     | 345.7   |

*   **Analysis:** The table shows a mixed picture.
    *   **CAGR:** Varies significantly across periods, with recent years showing weaker growth.
    *   **MDD:** Maximum Drawdown is consistently high, indicating significant potential for loss during downturns.
    *   **Alpha:** Fluctuates, with some periods showing outperformance relative to the market (positive alpha) and others underperformance (negative alpha). The most recent period shows a very significant negative alpha.
    *   **Beta:** Consistently low, suggesting PG is less sensitive to overall market movements than the S&P 500.
    *   **Cap:** Market Cap (Billion)

**2) Recent Price Action:**

*   **Current Price:** 147.67
*   **Last Market:** Price Change -0.2
*   **5-Day Moving Average:** 147.536
*   **20-Day Moving Average:** 149.1133
*   **60-Day Moving Average:** 152.7346

*   **Analysis:** The price is below all moving averages, suggesting a short-term downtrend. The most recent price change is slightly negative.

**3) Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 37.06 (Approaching oversold territory, potentially indicating a buying opportunity)
*   **PPO:** 0.0707
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent Relative Disparity Change (20-day):** 2.0 (+), indicating a short-term increase.
*   **Expected Return (%):** 113.6%

*   **Analysis:**
    *   The MRI suggests a medium level of risk.
    *   The RSI suggests the stock might be oversold and could be due for a rebound.
    *   The positive change in relative disparity hints at recent positive momentum.
    *   The high expected return suggests significant potential upside if held long-term.

**4) Recent News & Significant Events:**

*   **Nelson Peltz's Strategic Moves:** U-Haul Holding Co Exit Impacts Portfolio by -0.56%
*   **Jim Cramer Says Procter & Gamble “Has the Scale and the Science to Make Things Cheaper”**
*   **Jim Cramer Says Kenvue’s Brands “Complement Kimberly-Clark Perfectly”**
*   **The Zacks Analyst Blog Highlights Apple, Procter & Gamble and UnitedHealth**
*   **P&G’s Cascade Celebrates 70 Years by Partnering with Feeding America® to Support Families Facing Hunger, Helping to Provide Up to 1 Million Meals**
*   **Top Analyst Reports for Apple, Procter & Gamble and UnitedHealth**

*   **Analysis:** The news is a mixed bag.  The Nelson Peltz news indicates some portfolio adjustments. Positive news from Jim Cramer about P&G's scale and science is encouraging.  The Cascade/Feeding America partnership is positive for public image.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~2.00 on a 1-5 scale)
*   **Number of Opinions:** 22
*   **Target Price:** Average: 169.05, High: 186.00, Low: 148.00

*   **Analysis:** Analysts generally have a positive outlook on PG, with a consensus "Buy" rating. The average target price suggests potential upside from the current price.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
| :----------- | :--- | :------------ |
| 2025-10-24 | 2.00 | 22.39 B$ |
| 2025-04-24 | 1.58 | 19.78 B$ |
| 2025-01-22 | 1.94 | 21.88 B$ |
| 2024-10-18 | 1.65 | 21.74 B$ |
| 2025-10-24 | 1.65 | 21.74 B$ |

*   **Analysis:** Earnings per share (EPS) and Revenue fluctuates slightly over the recent quarters.

**6) Financial Information:**

*   **Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
| :------------- | :---------- | :-------------- |
| 2025-09-30 | $22.39B   | 51.37%        |
| 2025-06-30 | $20.89B   | 49.11%        |
| 2025-03-31 | $19.78B   | 50.98%        |
| 2024-12-31 | $21.88B   | 52.39%        |
| 2024-09-30 | $21.74B   | 52.06%        |

*   **Capital and Profitability:**

| Quarter      | Equity      | ROE    |
| :------------- | :---------- | :----- |
| 2025-09-30 | $53.27B   | 8.92%  |
| 2025-06-30 | $52.01B   | 6.95%  |
| 2025-03-31 | $52.27B   | 7.21%  |
| 2024-12-31 | $51.17B   | 9.05%  |
| 2024-09-30 | $51.84B   | 7.64%  |

*   **Analysis:** Revenue has some variation, and profit margins are consistently strong. Equity has generally increased, while ROE has fluctuated.

**7) Overall Summary:**

*   PG has significantly underperformed the S&P 500 historically.
*   Recent price action suggests a short-term downtrend, but the RSI hints at a potential buying opportunity.
*   Analysts have a positive outlook, with a "Buy" consensus and potential upside based on target prices.
*   The company maintains strong profit margins and a reasonable ROE.
*   While recent Alpha values are concerning, the long-term expected return is high.

**Investment Recommendation:**

Based on this analysis, PG appears to be a medium-risk investment with potential for long-term outperformance, particularly if the company can address the recent underperformance relative to the S&P 500. The analyst consensus and strong financials support a cautious "Buy" approach, especially for long-term, buy-and-hold investors. However, the recent negative Alpha and the price being below moving averages suggest caution in the short term. A gradual accumulation strategy might be appropriate.
